- Comp & Benefits
- Work/Life Balance
- Senior Management
- Culture & Values
- Career Opportunities
I worked at Leerink Swann full-time for more than 3 yearsPros
Everyone was driven and friendlyCons
Dog eat dog atmosphere at timesRecommendsNeutral OutlookApproves of CEO
Getting an Interview
Getting an Interview
1 person found this helpfulApplication Details
I applied through college or university. The process took a day - interviewed at Leerink Swann in March 2012.Interview Details
Interviewed via on-campus recruiting, had a 1:1 45 minute interview, by a mid-level employee who did not give off the friendliest vibe - he did not help my motivation and enthusiasm for the company.
It started off with just a few behavioral questions, going through my resume. Then was a simple case study question that involved analyzing a graph - explaining trends, etc. He then asked a healthcare specific question, where I chose a promising field and he walked through the stages of development, and asked questions about strategy.
Overall, and looking back, first round was pretty straight-forward as long as you know something about the industry. I guess I wasn't interested in it when I interviewed, and it showed.Interview Questions
No OfferNeutral ExperienceAverage Interview
- Strategy you would use to market the specific product/technology that you chose in the previous question (what development do you think is promising). View Answer
Let us know if we're missing any workplace or industry recognition –
If you're looking for an investment that will produce some healthy returns, Leerink Swann could have the right prescription. The investment bank provides brokerage, equity research, corporate finance, and strategic advisory services to companies and institutional investors in the health care and life sciences fields. Research areas include biotechnology, pharmaceuticals, medical devices, health care facilities, and health care technology. Leerink Swann also provides investment advisory services to life sciences companies, medical professionals, and high-net-worth investors.